RxDoctor Payments Data

Beverly Randle

Nurse Practitioner · Louisville, MSNPI 1184675134

Payments from drug & device makers

$3,062in general payments, 2019–2025

Across 177 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$847
  • Novo Nordisk$781
  • Lilly USA, LLC$356
  • Bayer$270
  • Amgen$159
  • Abbott$134
  • plus $515 from 11 others

What the payments were for

  • Food & beverage$3,062100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,062 in reported general payments places this provider in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol80$61,043
OzempicSemaglutide36$41,399
JanuviaSitagliptin Phosphate33$34,662
JardianceEmpagliflozin30$25,454
RybelsusSemaglutide15$21,845
EliquisApixaban29$17,442
Tresiba Flextouch U-100Insulin Degludec21$10,250
Repatha SureclickEvolocumab11$5,861
LantusInsulin Glargine,hum.Rec.Anlog28$2,747
Arnuity ElliptaFluticasone Furoate11$2,295
Atorvastatin Calcium265$1,466
Potassium Chloride73$1,273
Albuterol Sulfate HfaAlbuterol Sulfate43$1,238
SynthroidLevothyroxine Sodium17$979
Pantoprazole Sodium89$902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$781$63,24451 claims
AstraZenecaFarxiga$847$61,04380 claims
MerckJanuvia$80$34,66233 claims
Boehringer IngelheimJardiance$112$25,45430 claims
GSKArnuity Ellipta$17$2,29511 claims
AbbVieSynthroid$31$97917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Louisville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →